Posts

Showing posts with the label mitochondria

CoQ10 vs Ubiquinol vs Ubiquinone: The Difference and Studies?

Image
The antioxidant CoQ10, commonly referred to as coenzyme Q10, is one of the most well-liked dietary supplements for cardiovascular health in both the conventional medicine realm and the alternative or complementary medicine realm. It has also been linked in studies to regulating blood sugar, boosting fertility, preventing cancer, and even reducing migraines. As you age, your body produces less CoQ10. In addition, it has been discovered that statin users and patients with specific diseases, such type 2 diabetes mellitus (T2DM), have lower amounts of CoQ10. Restoring CoQ10 levels in T2DM patients may reduce oxidative stress, protect mitochondrial function, and ultimately result in better glycemic control. CoQ10 supplements may also help atrial fibrillation (a-fib), nonalcoholic fatty liver disease (NAFLD), insulin resistance, heart failure, cancer and migraines ( R ). We've seen a piqued interest in coenzyme Q10, with people curious abou...

Thomas Seyfried Cancer Treatment Protocol: Ketogenic Diet That Starves Cancer - A Comprehensive Guide (2026)

Image
Executive Summary Dr. Thomas N. Seyfried , Professor of Biology at Boston College, proposes a metabolic model of cancer that challenges the dominant genetic explanation and conventional oncology treatments. Rather than viewing cancer as primarily driven by gene mutations, Seyfried asserts it is fundamentally a metabolic disease centered on dysfunctional cellular energy production. This reframing draws on and expands the historical Warburg effect , emphasizing how cancer cells rely on fermentative metabolism of glucose and glutamine due to defective mitochondrial function.  A 2026 large-scale population study published in Nature Communications demonstrated that machine learning-predicted insulin resistance was associated with increased risk of 12 cancer types in nearly 500,000 individuals from the UK Biobank. This finding strengthens a growing thesis: Metabolic dysfunction is not merely a comorbidity — it may be a central modifiable axis in oncogenesis. Standard of Care: T...

Labels

Show more

Archive

Show more